In normal persons the administration of glucose orally or intravenously is associated with a decrease of serum inorganic phosphorus (1). Forsham and Thorn (2) 
(Submitted for publication July 14, 1953; accepted December 30, 1953) In normal persons the administration of glucose orally or intravenously is associated with a decrease of serum inorganic phosphorus (1) . Forsham and Thorn (2) and Schneeberg (3) have established that in most patients with diabetes mellitus the average fall in serum inorganic phosphorus is much less than the average fall found in patients who do not have this disease.
Intravenous glucose tolerance tests have been performed as part of a study on patients with essential hypertension admitted to the Columbia University Research Service, Goldwater Memorial Hospital, New York. Concomitant changes in serum inorganic phosphorus have been measured. The results of this study are reported. They indicate that some hypertensive patients who are nondiabetic (normal glucose tolerance test and no glycosuria) show serum phosphate curves similar to those previously described as occurring in diabetes mellitus (2, 3) .
METHOD
The individuals who served as a control series for this study and the patients with primary (essential) hypertension who comprise the experimental group were placed on a high-carbohydrate diet (minimum of 300 Gm.) for at least three days preceding the experimental period. The intravenous glucose tolerance tests were performd in the morning while the subjects were at rest and in the fasting state. After a fasting venous (6) .
RESULTS
Twenty-two individuals served as a control group. They included physicians, nurses, laboratory personnel, and patients hospitalized because of neurological disease or inactive rheumatoid arthritis. Their ages ranged from 35 to 68 years (average 52.5 years). There were 9 males and 13 females in this group. No individuals who had clinical or laboratory evidence of active infection, liver disease, or diabetes mellitus were included. However, many were chronically ill and had been confined to the hospital for many months. The data on each of these patients, grouped by decades, are presented in Table I .
The data elicited from patients with essential hypertension are presented in Table II Figure  2 ). Since the range of the pre-injection levels in both groups was wide, the changes after glucose administration have been depicted using the fasting level of each curve as the zero point. Inspection of this chart permits determination of the amount of overlap between the two groups. In evaluating the difference between the phosphate curves as depicted here, it should be recalled that the occurrence of the maximum fall in inorganic phosphate may appear from 20 to 90 minutes after glucose administration. As a result there will tend to be a levelling of the curves when a group of observations is placed together.
Knowledge of the accuracy of the method of phosphate determination is necessary in order to evaluate these results. One hundred two serum phosphate levels that had been examined in duplicate were analyzed statistically. The standard deviation between the two runs was 0.045. The standard error of the difference was 0.003. The method is, therefore, highly reproducible. 
